🔎 Trials Near Me

Hjem › Diffust intrinsisk pontin gliom › Washington

Diffust intrinsisk pontin gliom kliniske forsøg i Washington

10 studier for Diffust intrinsisk pontin gliom søger deltagere på steder i Washington.

Byer i Washington

Officiel studietekst (engelsk)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 21. sep. 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • Seattle Children's Hospital, Seattle
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 1 til 26 · Alle køn · Opdateret 4. aug. 2026 · NCT07680439

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Seattle Children's Hospital, Seattle
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 1 til 21 · Alle køn · Opdateret 29. jun. 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 2 til 39 · Alle køn · Opdateret 26. jun. 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Seattle Children's Hospital, Seattle
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Seattle Children's Hospital, Seattle
RekruttererTidlig fase 1
Op til 21 år · Alle køn · Opdateret 18. mar. 2026 · NCT04655404

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.